ELI LILLY & Co (LLY) Stock Analysis
HealthcarePharmaceutical Preparations
| Investor | 8Q history | Shares | Value | % of portfolio | Δ Q/Q | |
|---|---|---|---|---|---|---|
| 496.6K | $595.6M | 0.3 % | TRIM-22.1 % | 13F ↗ | ||
| 140.5K | $168.6M | 0.3 % | ADD+65.2 % | 13F ↗ | ||
| 87K | $104.4M | 0.4 % | ADD+22.9 % | 13F ↗ | ||
| 81.2K | $97.4M | 0.1 % | ADD+25.9 % | 13F ↗ | ||
| 77.3K | $92.7M | 0.6 % | ADD+509.5 % | 13F ↗ | ||
| 41.3K | $49.5M | 0 % | TRIM-1.8 % | 13F ↗ | ||
| 26.1K | $31.3M | 0 % | TRIM-63.7 % | 13F ↗ | ||
| 22.2K | $26.6M | 0.3 % | HOLD | 13F ↗ | ||
| 12.4K | $14.8M | 0.3 % | NEW | 13F ↗ |
13F filings cover long US equity positions only — no shorts, bonds or cash. “% of portfolio” refers to the manager’s reported 13F portfolio, not the entire fund. All facts come from public SEC filings with a link to the original document; this is not investment advice.